ClinicalResearchAssociate IQVIA Turkey is looking for talented and motivated team member to join our Sponsor... analytics, technology solutions and clinicalresearch services to the life sciences industry. We believe in pushing the...
ClinicalResearchAssociate IQVIA Turkey is looking for talented and motivated team member to join our Sponsor... IQVIA is a leading global provider of advanced analytics, technology solutions and clinicalresearch services to the life...
& Delivery, Collaboration, Partnership and Integrity. We want to be the ClinicalResearch Organisation that delivers excellence...Study Start Up Associate II At ICON, it’s our people that set us apart. Our diverse teams enable...
) to receive an alert: × Select how often (in days) to receive an alert: ClinicalResearchAssociate (CRA) - Talent Pipeline... expanding company? Join Novo Nordisk Turkey as ClinicalResearchAssociate (CRA) / Senior CRA and get a life-changing career...
Senior ClinicalResearchAssociate IQVIA is the Human Data Science Company oriented to drive human health outcomes... of clinicalresearch regulatory requirements Very good computer skills including MS Office Excellent command of Turkish...
& Delivery, Collaboration, Partnership and Integrity. We want to be the ClinicalResearch Organisation that delivers excellence... in English and Turkish Supporting the Study Start up Associate with tasks including; tracking, filling, collating...
. The position As a ClinicalResearchAssociate (CRA), you will conduct site selection, initiation, monitoring, and closure... next step in your professional development in a globally expanding company? Join Novo Nordisk Turkey as ClinicalResearch...
. As a ClinicalResearchAssociate at ICON, you’ll work within a large-scale, fast-paced environment alongside a close-knit team... and Integrity. We want to be the ClinicalResearch Organisation that delivers excellence to our clients and to patients at every...
Economic and Outcomes Research (HEOR) team to establish scientific and clinical credibility for clinical outcomes focused... affairs activities. An understanding of Good Clinical Practices, ICH guidelines, PhRMA code, FDACFR, ISO, clinicalresearch...
Economic and Outcomes Research (HEOR) team to establish scientific and clinical credibility for clinical outcomes focused... affairs activities. An understanding of Good Clinical Practices, ICH guidelines, PhRMA code, FDACFR, ISO, clinicalresearch...
England fans' reactions to the Three Lions' performances at Euro 2024 are "creating an unusual environment", says manager Gareth Southgate. Continue Reading »
Bharat Forge needs to achieve 15% consolidated sales growth in FY25 to meet Bloomberg consensus estimates.However, the consensus consolidated Ebitda estimate factors in a margin expansion of 200 bps. To achieve that, the subsidiaries must clock an Ebitda margin of almost 6% from 1% in FY24 Continue Reading »
Raymond stock: Today's surge in shares has propelled them to achieve a 251% gain over the past two years and an impressive 618% increase in just three years. Continue Reading »
TVS Motor Company and Bajaj Auto both offer promising long-term investment opportunities, with TVS leading in growth prospects and EV focus, while Bajaj excels in financial strength and diversification. Investors should assess risk tolerance and investment objectives for decision-making. Continue Reading »
No nation is buying as many aeroplanes as India right now, but the country has just a handful of aircraft manufacturing companies and aerospace equipment suppliers, and only two of them are listed. Continue Reading »
Top Gainers and Losers Today : The Sensex gained 620.73 points, or 0.8, to settle at 78053.52, while the Nifty gained 147.5 points, or 0.62, to close at 23721.3. Continue Reading »
Budget 2024: FPI flows have turned positive in last few sessions with election related uncertainties behind and supportive economic data. The valuations in the market nevertheless are stretched and volatility in flows may persist, while Budget outcome and Q1 earnings will provide trigger thereafter. Continue Reading »
Multibagger stock: The small-cap stock with a market cap of ₹1,651 crore has risen from around ₹23.25 to ₹74.60 per share in one year Continue Reading »
Auto ancillary sector has witnessed stock gains, with Lumax Auto among notable performers. The company's success lies in securing orders, expanding into EV segment. Sharekhan maintains a 'buy' rating with a target price of ₹650 per share. Continue Reading »